c-MYC antibody
Quick Overview for c-MYC antibody (ABIN498414)
Target
See all c-MYC (MYC) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- This antibody detects endogenous levels of c-Myc protein. (region surrounding Lys422)
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, Mouse.
-
Purification
- Affinity chromatography
-
Purity
- > 95 % by SDS-PAGE
-
-
-
-
Application Notes
-
Western Blot: 1/500 - 1/1000. Immunohistochemistry: 1/50 - 1/200. Immunfluorescence: 1/50 - 1/200.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1,0 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), pH 7.2., 15 mM sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- c-MYC (MYC) (Myc Proto-Oncogene protein (MYC))
-
Alternative Name
- C-Myc
-
Background
- The c-Myc protein is a transcription factor, which is encoded by the c-Myc gene on human chromosome 8q24. c-Myc is commonly activated in a variety of tumor cells and plays an important role in cellular proliferation, differentiation, apoptosis and cell cycle progression. The phosphorylation of c-Myc has been investigated and previous studies have suggested a functional association between phosphorylation at Thr58/Ser62 by glycogen synthase kinase 3, cyclin dependent kinase, ERK2 and C-Jun N terminal Kinase (JNK) in cell proliferation and cell cycle regulation. Studies also have shown that c-Myc is essential for tumor cell development in vasculogenesis and angiogenesis that distribute blood throughout the cells, and which brought extensive attention in the development of new therapeutic approach for cancer treatment.Synonyms: BHLHE39, Class E basic helix-loop-helix protein 39, Myc proto-oncogene protein, Transcription factor p64
-
Molecular Weight
- approx. 50 to 65 kDa
-
Gene ID
- 4609
-
NCBI Accession
- NP_002458
-
UniProt
- P01106
-
Pathways
- p53 Signaling, Cell Division Cycle, Sensory Perception of Sound, Transition Metal Ion Homeostasis, Mitotic G1-G1/S Phases, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus, Warburg Effect
Target
-